BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19539327)

  • 21. Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines.
    Saikawa Y; Kubota T; Maeda S; Otani Y; Kumai K; Kitajima M
    Oncol Rep; 2004 Sep; 12(3):527-31. PubMed ID: 15289832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo CpG island methylation in human cancer cells.
    Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
    Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXXC domain of human DNMT1 is essential for enzymatic activity.
    Pradhan M; Estève PO; Chin HG; Samaranayke M; Kim GD; Pradhan S
    Biochemistry; 2008 Sep; 47(38):10000-9. PubMed ID: 18754681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of DNA methyltransferase 1 expression in bovine fibroblast cells used for nuclear transfer.
    Giraldo AM; Lynn JW; Purpera MN; Vaught TD; Ayares DL; Godke RA; Bondioli KR
    Reprod Fertil Dev; 2009; 21(6):785-95. PubMed ID: 19567221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.
    Woodson K; Gillespie J; Hanson J; Emmert-Buck M; Phillips JM; Linehan WM; Tangrea JA
    Prostate; 2004 Jun; 60(1):25-31. PubMed ID: 15129426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
    Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B
    Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.
    Park J; Song SH; Kim TY; Choi MC; Jong HS; Kim TY; Lee JW; Kim NK; Kim WH; Bang YJ
    Oncogene; 2004 Apr; 23(19):3474-80. PubMed ID: 14990990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells.
    Damiani LA; Yingling CM; Leng S; Romo PE; Nakamura J; Belinsky SA
    Cancer Res; 2008 Nov; 68(21):9005-14. PubMed ID: 18974146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.
    Spada F; Haemmer A; Kuch D; Rothbauer U; Schermelleh L; Kremmer E; Carell T; Längst G; Leonhardt H
    J Cell Biol; 2007 Feb; 176(5):565-71. PubMed ID: 17312023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.
    Valinluck V; Sowers LC
    Cancer Res; 2007 Feb; 67(3):946-50. PubMed ID: 17283125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
    Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
    Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.
    Thangaraju M; Carswell KN; Prasad PD; Ganapathy V
    Biochem J; 2009 Jan; 417(1):379-89. PubMed ID: 18789002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation.
    Demers M; Couillard J; Giglia-Mari G; Magnaldo T; St-Pierre Y
    Biochem Biophys Res Commun; 2009 Sep; 387(3):425-9. PubMed ID: 19596268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of migration and invasion of PC3 prostate cancer cell line via activating E-cadherin expression by small activating RNA.
    Mao Q; Zheng X; Yang K; Qin J; Bai Y; Jia X; Li Y; Xie L
    Cancer Invest; 2010 Dec; 28(10):1013-8. PubMed ID: 20690797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
    Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
    Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
    Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells.
    Chen T; Hevi S; Gay F; Tsujimoto N; He T; Zhang B; Ueda Y; Li E
    Nat Genet; 2007 Mar; 39(3):391-6. PubMed ID: 17322882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin inhibits DNMT1, resulting in conditional apoptosis.
    Yokochi T; Robertson KD
    Mol Pharmacol; 2004 Dec; 66(6):1415-20. PubMed ID: 15340041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.